Procalcitonin (PCT) Predicts Worse Outcome in Patients with Chronic Heart Failure with Reduced Ejection Fraction (HFrEF)

INTRODUCTION: Procalcitonin (PCT) is an excellent marker of sepsis but was not extensively studied in cardiology. The present study investigated PCT plasma concentration in patients with chronic heart failure with reduced ejection fraction (HFrEF) and its prognostic value during 24-month follow-up....

Descripción completa

Detalles Bibliográficos
Autores principales: Banach, J., Wołowiec, Ł., Rogowicz, D., Gackowska, L., Kubiszewska, I., Gilewski, W., Michałkiewicz, J., Sinkiewicz, W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136577/
https://www.ncbi.nlm.nih.gov/pubmed/30245756
http://dx.doi.org/10.1155/2018/9542784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136577/
https://www.ncbi.nlm.nih.gov/pubmed/30245756
http://dx.doi.org/10.1155/2018/9542784

Ejemplares similares